SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.33), $0.11 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $17.49 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2025 revenue of $72-76 million, versus the consensus of $74.2 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.